These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3247662)

  • 21. The problems of studying disease-remittive agents in RA.
    Huskisson EC
    J Rheumatol Suppl; 1982; 8():201-6. PubMed ID: 6813486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evolution of seronegative arthritis].
    Ivanova MM; Akimova TF; Tsurko VV; Venikova MS
    Ter Arkh; 1986; 58(7):14-7. PubMed ID: 3764732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of pulmonary manifestations in patients with rheumatoid arthritis].
    Enomoto T; Azuma A; Murata A; Taniguchi Y; Nakahiro K; Takahashi T; Hashimoto Y; Kaneko Y; Abe S; Kudoh S; Hanji N; Yoshino S
    Arerugi; 1997 Nov; 46(11):1156-62. PubMed ID: 9436333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study.
    Pease CT; Haugeberg G; Montague B; Hensor EM; Bhakta BB; Thomson W; Ollier WE; Morgan AW
    Rheumatology (Oxford); 2009 Feb; 48(2):123-7. PubMed ID: 18980958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement activation by 19S IgM rheumatoid factor: relationship to disease activity in rheumatoid arthritis.
    Robbins DL; Fiegal DW; Leek JC; Shapiro R; Wiesner K
    J Rheumatol; 1986 Feb; 13(1):33-8. PubMed ID: 3701741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rheumatoid factor activity, age at manifestation and roentgenologic progression of rheumatoid arthritis--a retrospective study].
    Hein G; Eidner G; Eidner T; Marzoll I; Klinner M
    Z Rheumatol; 1993; 52(6):403-8. PubMed ID: 8147135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative evaluation of the efficacy and tolerance of gold and D-penicillamine preparations in patients with rheumatoid arthritis. II. The effect on the morphological indices of rheumatoid synovitis].
    Shekhter AB; Slobodina GA; Krel' AA; Kanevskaia MZ; Chichasova NV
    Revmatologiia (Mosk); 1990; (2):23-9; discussion 29-30. PubMed ID: 1977194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of auranofin as a rheumatoid remitting agent.
    Weisman MH; Hannifin DM; Guerra J; Resnik C; Resnick D
    J Rheumatol Suppl; 1982; 8():132-6. PubMed ID: 6813474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors.
    Lessard J; Nunnery E; Cecere F; McDuffy S; Pope RM
    J Rheumatol; 1983 Jun; 10(3):411-7. PubMed ID: 6604160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiological lesions of the hands in rheumatoid arthritis with rheumatoid factors and antinuclear antibodies].
    Punzi L; di Maggio C; Mazzi A; Presacco D; Ruffatti A; Pellegrini A; Todesco S
    Rev Rhum Mal Osteoartic; 1987; 54(7-9):563-6. PubMed ID: 3499656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral gold therapy with auranofin (SK&F 39162). A multicenter open study in patients with rheumatoid arthritis.
    Bandilla K; Gross D; Gross W; Herrlinger JD; Kriegel W; Müller W; Siegmeth W; Tausch G; Thumb N; Wagenhäuser FJ
    J Rheumatol Suppl; 1982; 8():154-9. PubMed ID: 6813478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Roentgeno-morphological comparisons in rheumatoid arthritis based on data of a long-term prospective study].
    Chichasova NV; Shekhter AB; Kanevskaia MZ; Krel' AA; Slobodina GA
    Revmatologiia (Mosk); 1990; (2):17-23. PubMed ID: 2218259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmarketing experience with auranofin in the Federal Republic of Germany.
    Schattenkirchner M; Missler B; Mulz D
    Scand J Rheumatol Suppl; 1986; 63():57-66. PubMed ID: 3299683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The moderate intestinal side effects of auranofin do not require prophylactic therapy with a bulkforming agent. Dutch Ridaura Study Group.
    van Beusekom HJ; van de Laar MA; Franssen MJ; van Valburg JA; Gijzel WP; Couvée JE
    Clin Rheumatol; 1997 Sep; 16(5):471-6. PubMed ID: 9348142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.
    Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J
    J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of serum IgG rheumatoid factor to IgM rheumatoid factor and disease activity in rheumatoid arthritis.
    Robbins DL; Feigal DW; Leek JC
    J Rheumatol; 1986 Apr; 13(2):259-62. PubMed ID: 3723492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis.
    Lovy MR; Starkebaum G; Uberoi S
    J Rheumatol; 1996 Jun; 23(6):979-83. PubMed ID: 8782126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.
    Rojas-Villarraga A; Diaz FJ; Calvo-Páramo E; Salazar JC; Iglesias-Gamarra A; Mantilla RD; Anaya JM
    J Autoimmun; 2009 Feb; 32(1):64-9. PubMed ID: 19117726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.